{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Kezar Life Sciences, Inc."},"Symbol":{"label":"Symbol","value":"KZR"},"Address":{"label":"Address","value":"4000 SHORELINE COURT,SUITE 300, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 822-5600"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program."},"CompanyUrl":{"label":"Company Url","value":"https://www.kezarlifesciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher J. Kirk","title":"Chief Executive Officer & Director"},{"name":"Kiruthi Palaniswamy","title":"Vice President-Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}